Background The burden of hepatitis C virus (HCV) infection is escalating among people who
inject drugs (PWID), yet testing and treatment remains suboptimal. The aim of this systematic …

The burden of hepatitis C infection is considerable among people who inject drugs (PWID),
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …

Globally, 12 million people are estimated to have injected drugs in the past year, 50% of
whom have chronic HCV infection, with people who have previously injected drugs …

Chronic hepatitis B virus (HBV) infection is a substantial global public health problem.
Despite the availability of a protective vaccine for more than 3 decades, the prevalence of …

Improving care and treatment for persons infected with hepatitis C virus (HCV) can reduce
HCV‐related morbidity and mortality. Our primary objective was to examine the HCV care …

Abstract Background In Baltimore, MD, as in many cities throughout the USA, overdose rates
are on the rise due to both the increase of prescription opioid abuse and that of fentanyl and …

Abstract Background Hepatitis C virus (HCV) infection is a major public health issue among
people who inject drugs (PWID) with prevalence of 50–80% in the United States. Effective …

The aim of this analysis was to evaluate perceived barriers related to HCV testing,
management and treatment among physicians practicing in clinics offering opioid agonist …

Gold standard quantitative nucleic acid tests for diagnosis of viral diseases are currently
limited to implementation in laboratories outside of the clinic. An instrument for conducting …

Current treatment for chronic hepatitis C (CHC) is highly efficacious, well-tolerated, and of
short duration for the majority of patients. Despite the dramatic advances in therapy, there …